ATS Investor Call

Sanofi was pleased to invite investors and analysts to participate in its ATS Investor Call on Monday, May 22, 2023.

(18h00 – 19h30 CEST / 12:00pm – 1:30pm EDT)


Dietmar Berger, MD, PhD

Global Head of R&D ad interim

Bill Sibold

Executive Vice President, Specialty Care

Naimish Patel, MD

Therapeutic Area Head, Immunology & Inflammation

Elizabeth Laws, PhD

Global Program Head, Dupixent

Klaus F. Rabe, MD, PhD, FERS

Professor of Medicine, LungenClinic Großhansdorf, Germany

Surya P. Bhatt, MD, MSPH

Associate Professor of Medicine, University of Alabama at Birmingham



Press Release